A $93 billion plunge in Novo Nordisk A/S shares has provided the latest blow to Europe’s largest listed companies, which have spent another year struggling in vain to match the returns of Wall Street’s biggest stocks.
Europe’s Big Stocks Are Shrinking Deeper Into US Megacaps’ Shadow
Date:


